Unofficial. This site is an experimental reformatting of data published by NHS England. It is not endorsed by NHS England. Always check the official Data Uses Register before relying on anything here.

NDRS Cancer Consolidated Data Set

Agreements naming it
37
In term in September 2026
35
Organisations
25
Files released
53

Files released counts only files released externally by DARS. Access granted in NHS England's own systems, such as its Secure Data Environment, is not included.

How the register describes it

Recorded against the dataset on each agreement, and not always the same from one agreement to the next, so every value found is listed.

Type of data
  • Anonymised - ICO Code Compliant
  • Identifiable
Sensitivity
  • Non-Sensitive
  • Sensitive
Frequency of release
  • Frequent Adhoc Flow
  • One-Off
  • Ongoing
  • System Access
Legal basis for provision
  • Consent (Reasonable Expectation)
  • Health and Social Care Act 2012 - s261(2)(d)
  • Health and Social Care Act 2012 - s261(5)(d)
  • Health and Social Care Act 2012 – s261(2)(a)
  • Health and Social Care Act 2012 – s261(2)(c)
  • National Health Service Act 2006 - s251 - 'Control of patient information'.

Organisations whose agreements name it (25)

Show the list, with the number of agreements for each

With an agreement in term in September 2026 (23)

With expired agreements only (2)

Agreements covering this dataset

Showing all 37 agreements.

Files: files of this dataset released under the agreement, across all its versions.

Agreements covering NDRS Cancer Consolidated Data Set
AgreementOrganisationTypeFilesLatest termStatusCommercial
Survival Improvement with Colecalciferol in Patients on Dialysis – The SIMPLIFIED Registry Trial DARS-NIC-24422-R3W3S University of Cambridge Academic 8 13 August 2026 to 31 December 2030 In term No
Centre for Health Economics, University of York, Programme Level Agreement DARS-NIC-667040-B5T1X University of York Academic 3 10 April 2026 to 19 November 2029 In term No
United Kingdom COVID and Gynaecological Cancer Study - UKCOGS ( ODR2021_178 ) DARS-NIC-682565-F6C6T Queen Mary University of London Academic 0 6 August 2026 to 5 August 2029 In term No
POSNOC - POsitive Sentinel NOde: adjuvant therapy alone versus adjuvant therapy plus Clearance or axillary radiotherapy. A randomised controlled trial of axillary treatment in women with early stage breast cancer who have metastases in one or two sentinel nodes DARS-NIC-688223-X1W4R University of Nottingham Academic 0 24 April 2026 to 23 April 2029 In term No
MyMelanoma database DARS-NIC-737123-P6P6G University of Oxford Academic 2 27 March 2026 to 26 March 2029 In term No
Inflammatory bowel disease-associated lymphoma DARS-NIC-785339-D9Q2D The Newcastle upon Tyne Hospitals NHS Foundation Trust NHS Trust 1 29 May 2026 to 12 March 2029 In term No
D1.1 - UK Health Security Agency (UKHSA) Single Data Sharing Agreement DARS-NIC-343380-H5Q9K UK Health Security Agency Agency/Public Body 4 13 March 2026 to 12 March 2029 In term No
The Early Detection of Hepatocellular liver cancer (DeLIVER) DARS-NIC-782177-G5W5G University of Oxford Academic 1 6 March 2026 to 28 February 2029 In term No
Cancer long-term follow-up study of clinical trial participants DARS-NIC-779200-S6R2D University College London (UCL) Academic 3 5 December 2025 to 4 December 2028 In term Yes
SINGLE SIGMOIDOSCOPY SCREENING IN PREVENTION OF BOWEL CANCER(The UK Flexible Sigmoidoscopy Screening Trial; UKFSST) DARS-NIC-148071-QHNM8 Imperial College London Academic 1 21 November 2025 to 20 November 2028 In term No
A National Study Of Breast Cancer And A Range Of Late Effects Of Hodgkin Lymphoma Treatments In Women (ODR1516_470) DARS-NIC-659282-H1F7C The Royal Marsden NHS Foundation Trust NHS Trust 3 10 June 2026 to 1 September 2028 In term No
IBIS-II Prevention & DCIS (Observational) DARS-NIC-324220-P6W9Y Queen Mary University of London Academic 1 22 August 2025 to 31 August 2028 In term No
YORKSURe: Early detection of bladder cancer in Yorkshire: Feasibility assessments for implementing a targeted study in populations with high disease specific mortality risk (Line Listing) DARS-NIC-626153-S6J6V King's College London Academic 1 20 August 2025 to 19 August 2028 In term No
YORKSURe: Early detection of bladder cancer in Yorkshire: Feasibility assessments for implementing a targeted study in populations with high disease specific mortality risk (Cohort Matched) DARS-NIC-689987-Z6D2Z King's College London Academic 1 20 August 2025 to 19 August 2028 In term No
Yorkshire Lung Screening Trial (consent) DARS-NIC-732228-T8Q0V Leeds Institute of Health Sciences Academic 2 17 July 2025 to 16 July 2028 In term No
Yorkshire Lung Screening Trial (s251) DARS-NIC-788403-Y9M1G Leeds Institute of Health Sciences Academic 2 17 July 2025 to 16 July 2028 In term No
Inequalities in cancer care pathways DARS-NIC-777554-J2V4K University College London (UCL) Academic 3 29 April 2026 to 8 May 2028 In term No
Department of Health and Social Care (DHSC) SDE access - Enabling Policy Analysis DARS-NIC-484452-H8S1L Department of Health and Social Care Ministerial Department 0 11 July 2025 to 24 April 2028 In term No
Prostate cancer treatment patterns and outcomes by ethnicity: a national cohort study using routinely collected data DARS-NIC-709342-K9Z8V Queen Mary University of London Academic 0 28 March 2025 to 27 March 2028 In term No
Equity of access to liver transplantation in the UK (EquiLT-UK): impact of socio-demographic characteristics on registration, organ offering, allocation and transplant outcomes. DARS-NIC-742898-S7N0V NHS Blood and Transplant (NHSBT) Agency/Public Body 1 23 March 2025 to 22 March 2028 In term No
Indigo (Investigating Digital Outcomes) - Participant led electronic completion of PROMs and PREMs for patients living with and beyond cancer DARS-NIC-747046-T7C5C Imperial College Healthcare NHS Trust NHS Trust 4 21 March 2025 to 20 March 2028 In term No
AspECT EXceL- Aspirin Esomeprazole Chemoprevention Trial- Consenting Subset of the Cohort DARS-NIC-644891-N5T3S University College London (UCL) Academic 1 21 February 2025 to 20 February 2028 In term No
AspECT EXceL- Aspirin Esomeprazole Chemoprevention Trial- Section 251 Subset of the Cohort DARS-NIC-776114-J7Q9J University College London (UCL) Academic 1 21 February 2025 to 20 February 2028 In term No
Fitness for purpose of data sources relevant for real-world data (RWD) studies on CAR-T cell therapy DARS-NIC-698157-B0L5B Certara UK Commercial 0 23 December 2025 to 22 December 2027 In term No
EPIC-Oxford. A prospective cohort study of 65,000 mainly vegetarian men and women, to examine how diet influences the risk of cancer, particularly for the most common types of cancer in Britain, as well as other chronic diseases. DARS-NIC-148322-TMFVQ University of Oxford Academic 3 6 December 2024 to 5 December 2027 In term No
PROSPECTIVE STUDY OF OUTCOMES IN SPORADIC VERSUS HEREDITARY BREAST CANCER (POSH) DARS-NIC-148334-51PXR University of Southampton Academic 3 3 December 2024 to 2 December 2027 In term No
SDE - NICE DARS-NIC-610798-N0G8Z National Institute for Health and Care Excellence (NICE) Agency/Public Body 0 15 May 2026 to 1 June 2027 In term No
Enumerating the impact of COVID-19 on cancer pathways: a robust evaluation of the NHS Digital Trusted Research Environment DARS-NIC-402417-N9Z5W University of Leeds Academic 0 3 April 2026 to 27 April 2027 In term No
University of Bristol - Longitudinal Linkage Collaboration - s251 cohort DARS-NIC-420229-G9H9S University of Bristol Academic 0 29 May 2026 to 31 March 2027 In term No
UK Longitudinal Linkage Collaboration (UK LLC) - Consent DARS-NIC-748729-Z8B3M University of Bristol Academic 0 23 March 2026 to 22 March 2027 In term No
Triple Negative Breast Cancer Study DARS-NIC-744993-Z8K2K Methods Business and Digital Technology Limited Supplier (IT) 0 5 June 2026 to 13 December 2026 In term Yes
IBIS-I The International Breast Cancer Intervention Study - MR710 DARS-NIC-12629-B4N5K Queen Mary University of London Academic 1 21 November 2025 to 20 November 2026 In term No
Evaluating the current standard of care for patients diagnosed with malignant melanoma of the head and neck – access to staging and surgical treatment. (ODR2122_2697) DARS-NIC-682532-B4B5L Hull University Teaching Hospitals NHS Trust NHS Trust 0 23 January 2026 to 13 October 2026 In term No
Investigating and explaining contemporary patterns and trends in inequalities across the head and neck cancer pathway: understanding the roles of deprivation and region DARS-NIC-726177-R0H8V University of Newcastle upon Tyne Academic 0 5 September 2025 to 29 September 2026 In term No
Treatment pathways and clinical outcomes in BCG-unresponsive non-muscle-invasive bladder cancer DARS-NIC-773953-N5L3H Tolley Ltd Supplier 0 22 September 2025 to 21 September 2026 In term Yes
The Role of Selective Neck Dissection Used Electively in Patients DARS-NIC-147858-KGYSS Saving Faces - The Facial Surgery Research Foundation Charity 3 14 April 2025 to 20 June 2026 Expired No
Health Burden of COVID-19 and Healthcare Resource Utilisation in England - INvestigation oF cOvid-19 Risk among iMmunocompromised populations DARS-NIC-561357-X0F3N Evidera Ltd Research 0 7 March 2025 to 14 November 2025 Expired Yes

Cite this page

NHS England (2026) Data Uses Register, September 2026 edition, agreements naming NDRS Cancer Consolidated Data Set. Read via NHS Data Access Explorer (unofficial), https://healthdatauses.uk/datasets/ndrs-cancer-consolidated-data-set/ (accessed [date]).

This address stays the same, but the page is rebuilt with each monthly edition, so the citation names the edition it shows. Every edition's data is kept in the facts store.